Mothers | Neonates | ||||||||||
No | Age | Diagnosis | Ro52 | Ro60 | La | Other Ab | Treatment | GA at birth | Sex | Weight (g) | Length (cm) |
Anti-Ro/La positive pregnancies | |||||||||||
1 | 35 | – | + | + | + | – | – | 38+2 | M | 3570 | 46 |
2 | 34 | SS | + | + | – | – | – | 40+0 | M | 3080 | 48 |
3 | 34 | SS | + | + | – | – | – | 30+5 | F | 1510 | 40 |
4 | 32 | – | + | + | + | – | – | 39+2 | M | 2880 | 50 |
5 | 37 | SLE/SS | + | + | + | Cardiolipin, Beta-2-glycoprotein | – | 40+3 | F | 4270 | 53 |
6 | 29 | SS | + | + | + | – | – | 40+1 | F | 3705 | 51 |
7 | 34 | SLE | + | + | + | RNP-A | – | 40+5 | M | 3580 | 53 |
8 | 36 | SS | + | + | – | Cardiolipin, RF- | – | 40+2 | M | 3840 | 51 |
9 | 37 | SS | + | + | – | RF | – | 41+6 | M | 3330 | 51 |
10 | 29 | SS | + | + | + | Nucleosome | – | 41+1 | M | 4070 | 54 |
11 | 30 | – | + | + | – | – | – | 40+5 | F | 3065 | 51 |
12 | 27 | SLE | + | – | + | – | Plaquenil | 40+0 | M | 3220 | 51 |
13 | 32 | RA | + | + | + | RF, CCP | Prednisolone | 39+2 | M | 4375 | 52 |
14 | 24 | SLE/SS | + | + | – | – | Plaquenil, Prednisolone | 38+2 | F | 2790 | 49 |
15 | 30 | SLE | + | + | – | Nucleosome, Ribosomal P, dsDNA | Plaquenil, Prednisolone | 39+0 | F | 2405 | 50 |
16 | 31 | SLE | + | + | – | Nucleosome, dsDNA | Plaquenil, Azathioprine | 37+4 | M | 2790 | 49 |
17 | 35 | – | + | + | + | – | – | 41+3 | F | 3310 | 51 |
18 | 35 | SS | + | + | + | – | – | 38+2 | M | 3470 | 50 |
19 | 34 | SS | + | + | + | Cryoglobulin | – | 38+1 | M | 3254 | 49 |
20 | 34 | – | + | – | – | – | – | 41+2 | F | 2902 | 52 |
21 | 36 | SS | + | + | + | RF | – | 40+5 | F | 3420 | 50 |
22 | 36 | Polyarthritis | + | + | + | – | Plaquenil, Prednisolone | 38+3 | M | 3170 | 47 |
23 | 33 | Myositis | + | + | – | Nucleosome, RNP-68, SmRNP, dsDNA | Prednisolone | 40+2 | M | 3270 | 50 |
24 | 28 | SLE | + | – | + | – | Plaquenil | 38+1 | F | 3336 | 52 |
25 | 35 | SLE | + | + | – | Nucleosome, SmRNP | – | 38+0 | F | 3520 | 51 |
Mean | 32.5 | 39+5 | 3428 | 50 | |||||||
Healthy control pregnancies | |||||||||||
1 | 39 | – | – | – | – | – | – | 38+6 | M | 3590 | 50 |
2 | 31 | – | – | – | – | – | – | 42+1 | M | 3945 | 51 |
3 | 39 | – | – | – | – | – | – | 38+5 | M | 3742 | 52 |
4 | 29 | – | – | – | – | – | – | 38+5 | F | 2970 | 48 |
5 | 31 | – | – | – | – | – | – | 39+3 | F | 3900 | 51 |
6 | 37 | – | – | – | – | – | – | 38+5 | F | 3290 | 49 |
7 | 27 | – | – | – | – | – | – | 39+5 | F | 3670 | 53 |
8 | 36 | – | – | – | – | – | – | 41+2 | M | 3720 | 52 |
9 | 39 | – | – | – | – | – | – | 38+4 | M | 2984 | 52 |
10 | 33 | – | – | – | – | – | – | 38+5 | F | 3098 | 49 |
11 | 40 | – | – | – | – | – | – | 39+2 | F | 3474 | 50 |
12 | 31 | – | – | – | – | – | – | 39+3 | M | 3745 | 50 |
13 | 32 | – | – | – | – | – | – | 40+6 | F | 3790 | 53 |
14 | 23 | – | – | – | – | – | – | 39+1 | F | 3270 | 51 |
15 | 37 | – | – | – | – | – | – | 41+5 | M | 3832 | 51 |
16 | 27 | – | – | – | – | – | – | 41+4 | F | 5182 | 55 |
17 | 41 | – | – | – | – | – | – | 38+6 | M | 3280 | 50 |
18 | 37 | – | – | – | – | – | – | 40+1 | M | 3685 | 50 |
19 | 37 | – | – | – | – | – | – | 38+4 | F | 3310 | 51 |
20 | 33 | – | – | – | – | – | – | 38+2 | F | 2636 | 49 |
21 | 31 | – | – | – | – | – | – | 39+2 | F | 3652 | 48 |
22 | 41 | – | – | – | – | – | – | 39+3 | M | 3136 | 49 |
23 | 31 | – | – | – | – | – | – | 39+1 | M | 4142 | 50 |
24 | 44 | – | – | – | – | – | – | 40+5 | F | 3660 | 51 |
25 | 38 | – | – | – | – | – | – | 40+6 | M | 3990 | 54 |
Mean | 35.8 | 40+0 | 3589 | 50.7 |
RA, Rheumatoid arthritis; SLE, systemic lupus erythematosus; SS, Sjögren’s syndrome.